StockUS listing USCBLLNASDAQHealthcareProfitless Growth

CeriBell, Inc(CBLL) Stock Analysis | Healthcare

USD --+0.00%
Reward58Moderate
Risk49Moderate
75%Data
Thin -68% profit margin · Revenue growing 30% YoY
USD —+0.00 (+0.00%) Previous close · NASDAQ
Market cap 1.06Bn
Reward Ratingⓘ58 Moderate reward assessment · 75% data coverage
Top 50% of stocksView factors
Risk Ratingⓘ49 Moderate risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on CBLL to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is CeriBell, Inc?

operates as a medical technology company in the United States.

AI Brief Pro

The brief on CeriBell, Inc

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is CeriBell, Inc?

operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.06B.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (58)

Similar stocks to compare

A short list of Medical Devices names that are close enough in size to make side-by-side comparison useful.

Company Information
SectorHealthcare
IndustryMedical Devices
Beta0.859
Insider Activity
12M windowBearish
Shares soldShares bought
0-3months
14139,859 shares
$3.6M
0
3-6months
643,337 shares
$1.1M
0
6-9months
0
0
9-12months
0
0